| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Department of Oncology [S. E. H. R., M. M., J. F. B., P. G. D., S. C., S. W. C., S. M., D. P. H., G. W. K., A. N. C., P. G. J.], School of Biology and Biochemistry [I. H.], The Queens University of Belfast, Belfast BT9 7AB, United Kingdom; Department of Internal Medicine, University of Michigan, Michigan 48109-0638 [E. M. P., L. M. K.]; and Genethon 1, 91002 Evry Cedex, France [J. W.]
Allele losses from chromosome 17 are common in sporadic ovarian tumors.
Previously, we reported high rates of LOH (up to 70%) from 17q25 at
the marker THH59 in a bank of malignant ovarian tumors. We have
extended this study to 70 tumors with 17 markers from the long arm of
chromosome 17. In most cases, the data are consistent with whole
chromosome loss, but we have identified a minimal region of deletion
that is centered around 4 microsatellites with zero recombination at
map position 106.9 cM. A P1/BAC contig across the region (
200 kb)
was constructed and used to determine the precise position and order of
the microsatellites. The contig was shown to hybridize to 17q25 by
fluorescence in situ hybridization analysis. The DNA
sequence of the entire contig was determined and analyzed by BLAST
searches. A 4-kb cDNA was subsequently identified with homology to the
yeast, Drosophila and mammalian septin family of genes. We have
designated this gene Ovarian/Breast (Ov/Br) septin. Two
splice variants were demonstrated within the 200-kb contig, which
differ only at exon 1. Within the contig,
45% of the septin
transcript was identified and 38% of the septin
ß transcript. The septins are a family of
genes involved in cytokinesis and cell cycle control. Their known
functions are consistent with the hypothesis that the human 17q25
septin gene is a candidate for the ovarian tumor
suppressor gene.
This article has been cited by other articles:
![]() |
M. E. Gonzalez, E. A. Peterson, L. M. Privette, J. L. Loffreda-Wren, L. M. Kalikin, and E. M. Petty High SEPT9_v1 Expression in Human Breast Cancer Cells Is Associated with Oncogenic Phenotypes Cancer Res., September 15, 2007; 67(18): 8554 - 8564. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. McDade, P. A. Hall, and S.E. H. Russell Translational control of SEPT9 isoforms is perturbed in disease Hum. Mol. Genet., April 1, 2007; 16(7): 742 - 752. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Xinarianos, F. E. McRonald, J. M. Risk, N. L. Bowers, G. Nikolaidis, J. K. Field, and T. Liloglou Frequent genetic and epigenetic abnormalities contribute to the deregulation of cytoglobin in non-small cell lung cancer Hum. Mol. Genet., July 1, 2006; 15(13): 2038 - 2044. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ono, M. Ihara, H. Nakajima, K. Ozaki, Y. Kataoka-Fujiwara, T. Taki, K.-i. Nagata, M. Inagaki, N. Yoshida, T. Kitamura, et al. Disruption of Sept6, a Fusion Partner Gene of MLL, Does Not Affect Ontogeny, Leukemogenesis Induced by MLL-SEPT6, or Phenotype Induced by the Loss of Sept4 Mol. Cell. Biol., December 15, 2005; 25(24): 10965 - 10978. [Abstract] [Full Text] [PDF] |
||||
![]() |
W W J de Leng, J J Keller, S Luiten, A R Musler, M Jansen, A F Baas, F W M de Rooij, J J P Gille, F H Menko, G J A Offerhaus, et al. STRAD in Peutz-Jeghers syndrome and sporadic cancers J. Clin. Pathol., October 1, 2005; 58(10): 1091 - 1095. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-i. Nagata, T. Asano, Y. Nozawa, and M. Inagaki Biochemical and Cell Biological Analyses of a Mammalian Septin Complex, Sept7/9b/11 J. Biol. Chem., December 31, 2004; 279(53): 55895 - 55904. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Zucchi, E. Mento, V. A. Kuznetsov, M. Scotti, V. Valsecchi, B. Simionati, E. Vicinanza, G. Valle, S. Pilotti, R. Reinbold, et al. Gene expression profiles of epithelial cells microscopically isolated from a breast-invasive ductal carcinoma and a nodal metastasis PNAS, December 28, 2004; 101(52): 18147 - 18152. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Martinez and J. Ware Mammalian Septin Function in Hemostasis and Beyond Experimental Biology and Medicine, December 1, 2004; 229(11): 1111 - 1119. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-i. Nagata, A. Kawajiri, S. Matsui, M. Takagishi, T. Shiromizu, N. Saitoh, I. Izawa, T. Kiyono, T. J. Itoh, H. Hotani, et al. Filament Formation of MSF-A, a Mammalian Septin, in Human Mammary Epithelial Cells Depends on Interactions with Microtubules J. Biol. Chem., May 9, 2003; 278(20): 18538 - 18543. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Montagna, M.-S. Lyu, K. Hunter, L. Lukes, W. Lowther, T. Reppert, B. Hissong, Z. Weaver, and T. Ried The Septin 9 (MSF) Gene Is Amplified and Overexpressed in Mouse Mammary Gland Adenocarcinomas and Human Breast Cancer Cell Lines Cancer Res., May 1, 2003; 63(9): 2179 - 2187. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Surka, C. W. Tsang, and W. S. Trimble The Mammalian Septin MSF Localizes with Microtubules and Is Required for Completion of Cytokinesis Mol. Biol. Cell, October 1, 2002; 13(10): 3532 - 3545. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-R. Peng, Z. Jia, Y. Zhang, J. Ware, and W. S. Trimble The Septin CDCrel-1 Is Dispensable for Normal Development and Neurotransmitter Release Mol. Cell. Biol., January 1, 2002; 22(1): 378 - 387. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |